一种合成4β-甲基-5α胆甾烷的新路线

本文报道以胆甾醇为原料经四步反应立体控制合成4β-甲基-5α-胆甾烷(6)的新路线。4-甲基胆甾-4-烯-3-酮(3)经Clemmensen还原,得4-甲基胆甾-4-烯(4)(65％)及4-甲基胆甾-3-烯(5)(15％)。用10％Pd-C在无水乙醇中室温催化氢化4,得6(70％)与4α-甲基-5α- 胆甾烷(7)(30％)的混合物;而选用Brown催化剂在同样条件下氢化4,得到产物6与7的比例为95:5。     

生物标志化合物的合成研究 Ⅹ Ⅱ.4-甲基胆甾烷的合成新路线

本文报导以胆甾醇为原料经五步反应合成了4α—甲基—5α—胆甾烷与4β—甲基—5α—胆甾烷的混合物。其关键反应是利用胆甾—4—烯—3,6—二酮和重氮甲烷反应而引入4—甲基。     

N-杂芳基鹅脱氧胆酰胺化合物的合成及抗肿瘤活性研究

甾体类药物由于其特有的生理活性而被广泛应用于各种疾病的治疗。本文采用鹅脱氧胆酸为原料,通过Jones试剂氧化其3,7-位的羟基,然后进一步与不同的芳杂环氨反应,进一步还原羰基,合成了6个新的具有不同结构特征的甾体芳杂环酰胺衍生物,合成物经IR、NMR及HRMS进行结构表征。同时采用人胃癌细胞(SGC-7901)和肝癌细胞(Bel-7404)对合成物进行了体外抑制肿瘤细胞生长增殖活性测试,结果表明其中的3,7-二羟基鹅脱氧胆酸芳杂环酰胺衍生物对所测试肿瘤细胞株具有明显的抑制活性。     

具有特殊甾核结构甾体化合物的合成及生理活性研究进展

改变甾体的甾核结构,在甾核或支链中引入不同的官能团,可以得到一些具有不同生理活性的化合物.按照不同类型甾核结构分类,结合本课题组在具有特殊甾核结构甾体化合物的合成和生理活性研究方面所取得的一些成果,对近年来具有A-失碳甾体化合物、B-失碳甾体化合物及C-失碳-D-增碳甾体化合物的合成及生理活性进行讨论,并展望了此类化合物的发展趋势及应用前景.     

甾体肟醚化合物的合成及抗肿瘤活性研究

肟醚类化合物往往表现出很好的杀虫、除草、抗菌、抗病毒以及抗肿瘤等生理活性,因而受到人们的广泛关注.从胆甾醇、豆甾醇出发,通过不同的合成路线,制备得到系列3-取代、6-取代及22-取代甲氧基肟醚和苄氧基肟醚甾体化合物,通过IR、NMR及MS等现代分析方法对合成物进行了结构表征.同时,分别采用人胃癌细胞(SGC-7901)、人肝癌细胞(Bel-7404)和鼻咽癌细胞(CNE-2)对合成产物及部分合成中间体进行了体外抑制肿瘤细胞生长增殖活性研究.结果表明,某些具有22-取代结构的甲氧肟醚及苄氧肟醚甾体化合物对这些肿瘤细胞株表现出较好的抑制活性,其中22-降-3β-羟基-22-苄氧肟基-豆甾-6-缩胺硫腙(15)对人鼻咽癌细胞CNE-2的IC50值为5.7μmol/L.     

抗生育甾体化合物——7α-甲基-17β-羟基-雌甾-5-烯-3-酮的合成

以△~4-雌甾烯-3,17-二酮(5)为原料,经四步得到17β-羟基-△~(4,6)-雌甾二烯-3-酮(4),(4)与二甲基铜锂试剂经1,6共轭加成合成了目的物7α-甲基-17β-羟基-雌甾-5-烯-3-酮(2b)。经药理试验表明2b具有明显的抗着床及抗早孕活性。     

6-羟基-3-硫酸酯钠甾体化合物的合成及生理活性研究

甾醇硫酸酯钠化合物由于其独特的结构特征和特殊的生理活性正引起人们越来越多的关注.从天然存在的甾醇1a～1b出发,经过PCC氧化得到4-烯-3,6-二羰基甾体化合物2a～2b,然后在Ni2+存在的条件下用硼氢化钠还原2a～2b,得到3-羟基-6-酮甾体化合物3a～3b.利用三乙胺-三氧化硫复合物对3a～3b进行硫酸酯化得到4a～4b,然后通过阳离子(钠型)交换树脂对4a～4b进行Na+交换得到6-氧代-3β-硫酸酯钠盐5a～5b,5a～5b进一步通过NaBH4还原得到6-羟基-3β-硫酸酯钠(6a～6b).另外,采用类似的方法合成了6-羟基胆甾-4-烯-3β-硫酸酯钠(10a).并对化合物5a～5b和6a～6b进行抗肿瘤活性试验,结果表明6a在体外对卵巢癌(Hey-1B)细胞株具有较好的细胞毒性,IC50值为48 nmol/mL.     

甾体-17-酮肟的Beckmann裂解反应研究

研究了甾体-17-酮肟(1a～1i)在PCl5/2,6-二甲基吡啶/CH2Cl2体系中的Beckmann裂解反应.反应得到的烯-腈化合物(2a～2i)是18-去甲基甾体的重要中间体,其结构经1HNMR,IR,MS和元素分析表征.实验结果表明,1的取代基和构型对反应结果没有明显影响.     

中国南海海绵Cinachyrella australiensis中(3E)-胆甾-4-烯-3,6-二酮-3-肟的结构鉴定

从南中国海海绵Cinachyrella australiensis的乙酸乙酯萃取部分分离出一个结构特别的甾体化合物, 应用UV, IR, MS, ¹H NMR, ¹³C NMR, DQCOSY, NOESY, TOCSY, HMQC和HMBC等光谱分析技术, 确定它为(3E)-胆甾-4-烯-3,6-二酮-3-肟(1). 化合物1为新天然甾体化合物, 通过生理活性实验表明其对乙肝病毒Hep G2细胞有较强的细胞毒活性. 本文对其波谱数据作了详细报道.     

具有生理活性甾体腙类化合物的研究进展

按照取代基类型将甾体腙类化合物进行分类.主要概述了近六年来新合成及发现的甾体腙类化合物及其衍生物的生理活性及研究进展,并对此方面的发展趋势、应用前景作了展望.     

Novel Steroidal (6R)‐Spiro‐1,3,4‐thiadiazoline Derivatives as Anti‐bacterial Agents

Novel steroidal (6R)‐spiro‐1,3,4‐thiadiazoline derivatives have been synthesized by the cyclization of steroidal thiosemicarbazones. Thiosemicarbazones have been synthesized by the reaction of steroidal ketones with thiosemicarbazide. All the compounds have been characterized by IR, ¹H NMR, mass and elemental analyses. The antibacterial activities of these compounds have been first tested in vitro by the disk diffusion assay against two Gram‐positive and two Gram‐negative bacteria, and then the minimum inhibitory concentration (MIC) values have been determined with the reference of standard drug amoxicillin. The results showed that steroidal thiadiazoline derivatives exhibited better antibacterial activity than the steroidal thiosemicarbazone derivatives. Chloro and acetoxy substituents on the 3β‐position of the steroidal thiadiazoline ring increased the anti‐bacterial activity. Among all the compounds, compounds 7 and 8 were found better inhibitors as compared to the respective drug amoxicillin.     

Manganese Dioxide Mediated Stereoselective, One-step Synthesis of Novel Steroidal (6R)-Spiro-1’,2’,4’-triazoline-3’-thiones

Oxidative cyclization of 5α-cholestan-6-one thiosemicarbazone (1), its 3β-chloro (2) and 3β-acetoxy (3) analogues with active manganese dioxide at room temperature afforded selectively the corresponding (6R)-spiro-1’,2’,4’-triazoline-3’-thiones 4—6. This synthesis has the advantages of mild reaction conditions, easy handling, easily available reagent and high yields. The products have been characterized by analytical and spectral data.     

呋喃甾烷型皂甙的研究进展

综述了呋喃甾烷型皂甙(双糖链甾体皂甙)的结构特点、化学性质、生理活性和生源合成。列举了1966～1999年发现的双糖链甾体皂甙,共214个。     

25R/25S stereochemistry of spirostane‐type steroidal sapogenins and steroidal saponins via chemical shift of geminal protons of ring‐F

A method based on the differences among the ¹H NMR chemical shifts of geminal protons of ring‐F methylene resonances (H₂‐23, H₂‐24 and H₂‐26) is proposed for ascertaining the 25R/25S stereochemistry of ring‐F unsubstituted spirostane‐type steroidal sapogenins and steroidal saponins. Copyright © 2003 John Wiley & Sons, Ltd.     

Two new 14, 15-secopregnane-type steroidal glycosides from the roots of Cynanchum limprichtii

Two new steroidal glycosides 1 and 2, along with three known ones (3–5), were isolated from the 95% ethanol extract of the roots of Cynanchum limprichtii Schltr. The structure of the new compounds was elucidated as 3-O-α-L-diginopyranosyl-(1→4)-β-D-digitoxopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-thevetopyranosyl-14, 16:15, 20:18, 20-triepoxy-14, 15-secopregn-4, 6, 8 (14)-triene (1) and 3-O-α-L-cymaropyranosyl-(1→4)-β-D-digitoxopyranosyl- (1→4)-β-D-3-demethyl-2-deoxythevetopyranosyl-14, 16: 15, 20: 8, 20-triepoxy-14, 15-secopregn-5, 8 (14)-diene (2) on the basis of spectroscopic analysis together with acidic hydrolysis. All compounds showed cytotoxic activity against the human cancer cell line HL60, with IC₅₀ values of 55.36, 65.41, 17.88, 17.68 and 33.5 μM, respectively. While, only compound 3 showed cytotoxicity against the Caco-2 cell line, with an IC₅₀ value of 67.47 μM.     

Three new spirostanol glycosides from Helleborus thibetanus

Abstract

An ongoing chemical investigation on n-BuOH extract of roots and rhizomes of Helleborus thibetanus afforded three new spirostanol glycosides (1–3). Their structures were elucidated by extensive analysis of 1?D, 2?D NMR spectra, together with IR and MS methods and acid hydrolysis. This is the first report of the isolation of spirostanol glycoside with xylose at C-24 of the aglycone in Helleborus.     

7-位取代的甾体类化合物生物活性研究进展

7-位取代的甾体类化合物是一类具有良好生物活性的化合物,在抗炎、抗肿瘤等领域发挥着重要作用.本文以7-位取代的甾体类化合物为研究对象,按照不同的留体母核进行分类,对近年来有关7-位取代的甾体类化合物的生理活性研究进行综述,并为此类化合物的发展趋势和应用作了展望,以期为抗肿瘤药物的研发提供一定的理论基础.     

New stigmastane type of steroidal glycosides from the roots of Vernonia cumingiana

Two new stigmastane type of steroidal glycosides, vernoniacums A and B (1 and 2), with a △7,9(11) steroidal core were isolated from the roots of Vernonia cumingiana. Their structures were elucidated based on various spectroscopic techniques, including IR, HR-FAB-MS, and 1D and 2D NMR. Both compounds were evaluated for their cytotoxicity against HeLa and HCT-8 cells, and compound 1 showed mild activity against the tested cell lines with IC50 values of 15.8 and 35.7 pounds were evaluated for their cytotoxicity against HeLa and HCT-8 cells, and compound 1 showed mild activity against the tested cell lines with IC₅₀ values of 15.8 and 35.7 μM, respectively.     

新型甾体缀合物的设计合成及活性研究

甾体化合物是一类生物体中广泛存在并起重要功能的生物分子。其特殊结构使这类化合物具有亲脂性,膜亲合性以及与低密度脂蛋白的特异性结合等性能。利用这些特性设计合成各种药物分子的甾体缀合物,可增加药物分子的脂溶性,提高跨膜渗透能力,在特定组织中的分布以及甾体缀合物自身具有独特的生物活性,对探索新型生物活性分子具有重要意义。本文介绍了近年来在设计合成新型甾体缀合物领域的研究进展,包括甾体药物缀合物、含磷甾体缀合物、作为离子通道和分子载体的缀合物及甾体二聚缀合物等。